Cellistic

At Cellistic, our mission is to pioneer the development and manufacture of innovative cell therapies that harness the transformative potential of human induced pluripotent stem cell (iPSC) technology. Since our inception in April 2022, we have been dedicated to establishing partnerships with forward-thinking cell therapy developers, aiming to deliver novel advanced therapies that can significantly enhance patient outcomes.

Rooted in over a decade of scientific and technical expertise from our sister company, Ncardia, we pride ourselves on our commitment to excellence, quality, and integrity. Our core values revolve around collaboration, innovation, and a steadfast dedication to advancing the field of biotechnology. As we grow, our team of 90 talented professionals embodies a culture of support and continuous learning, fostering an environment where creativity thrives.

We believe that by empowering our employees and nurturing a diverse workforce, we can drive meaningful change in the life sciences sector. At Cellistic, we are not just creating products; we are shaping the future of healthcare through cutting-edge research and development. Join us in our journey to redefine possibilities in cell therapy and make a lasting impact on the world.